PDS Biotechnology Corporation (PDSB)
NASDAQ: PDSB · Real-Time Price · USD
1.175
+0.015 (1.29%)
Aug 14, 2025, 2:24 PM - Market open
PDS Biotechnology Market Cap
PDS Biotechnology has a market cap or net worth of $53.71 million as of August 14, 2025. Its market cap has decreased by -61.66% in one year.
Market Cap
53.71M
Enterprise Value
31.32M
1-Year Change
-61.66%
Ranking
Category
Stock Price
$1.18
Market Cap Chart
Since October 1, 2015, PDS Biotechnology's market cap has decreased from $334.50M to $53.71M, a decrease of -83.94%. That is a compound annual growth rate of -16.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 53.00M | -13.11% |
| Dec 31, 2024 | 61.00M | -60.54% |
| Dec 29, 2023 | 154.60M | -58.92% |
| Dec 30, 2022 | 376.30M | 63.40% |
| Dec 31, 2021 | 230.30M | 383.82% |
| Dec 31, 2020 | 47.60M | 211.11% |
| Dec 31, 2019 | 15.30M | 51.49% |
| Dec 31, 2018 | 10.10M | -96.51% |
| Dec 29, 2017 | 289.20M | -20.00% |
| Dec 30, 2016 | 361.50M | 0.39% |
| Dec 31, 2015 | 360.10M | 7.65% |
| Oct 1, 2015 | 334.50M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |